Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
RSV
Pharma
Moderna disappoints in RSV debut, excels in COVID sales
Moderna's RSV shot fell way short of expectations in its market debut, following disappointing results from its rivals GSK and Pfizer.
Kevin Dunleavy
Nov 7, 2024 10:51am
GSK's RSV vaccine sales plummet in wake of guidance changes
Oct 30, 2024 10:41am
Sanofi isn't sweating a potential RSV showdown with Merck
Oct 25, 2024 11:12am
GSK's Arexvy shows promise in younger adults
Oct 24, 2024 10:32am
FDA approves Pfizer's RSV shot Abrysvo for all at-risk adults
Oct 23, 2024 11:11am
GSK takes mRNA patent fight to Moderna
Oct 15, 2024 6:34pm
